SHE:002424 Revenue

Guizhou Bailing Group Pharmaceutical had revenue of 760.59M CNY in the quarter ending March 31, 2025, a decrease of -42.93%. This brings the company's revenue in the last twelve months to 3.25B, down -27.77% year-over-year. In the year 2024, Guizhou Bailing Group Pharmaceutical had annual revenue of 3.83B, down -10.26%.

Revenue (ttm)

3.25B

Revenue Growth

-27.77%

P/S Ratio

1.77

Revenue / Employee

493.96K

Employees

6,586

Market Cap

5.77B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.83B	-437.59M	-10.26%
Dec 31, 2023	4.26B	722.84M	20.42%
Jan 1, 2023	3.54B	429.01M	13.79%
Jan 1, 2022	3.11B	23.24M	0.75%
Dec 31, 2020	3.09B	237.30M	8.32%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Sichuan Biokin Pharmaceutical	5.82B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings